Observational analysis indicates cubosomes enhance drug delivery in cancer therapeutics, suggesting improved treatment outcomes.
Cubosomes are lipid vesicles that are comparable to vesicular systems like liposomes. Cubosomes are created with certain amphiphilic lipids in the presence of a suitable stabilizer. Since its discovery and designation, self-assembled cubosomes as active drug delivery vehicles have drawn much attention and interest. Oral, ocular, transdermal, and chemotherapeutic are just a few of the drugs delivery method in which they are used. Cubosomes show tremendous potential in drug nano formulation for cancer therapeutics because of their prospective advantage, which include high drug dispersal due to the structure of the cubic, large surface area a relatively simple manufacturing process, biodegradability, ability to encapsulate hydrophobic, hydrophilic, and amphiphilic compounds, mostly cubosomes look like a “honey combed” structure and are thermodynamically stable. Application of cubosomes includes treatment of skin, hair, and other body tissue using cubosomes-like vehicle activity of biological substance, regulated release of solubilized chemicals. Melanoma {cancer} therapy based on a size delivery system is the key to effectively targeting melanoma due to increased permeability and retention.
No takes yet. Share an insight, caveat, or question.
K et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: